Literature DB >> 21547540

Over-expression of Oct4 in human esophageal squamous cell carcinoma.

Xi Zhou1, Guang-Rong Huang, Pin Hu.   

Abstract

The Octamer 4 gene (Oct4) is a master pluripotency controller that has been detected in several types of tumors. Here, we examine the expression of Oct4 in human esophageal squamous cell carcinoma (ESCC). We found that punctate Oct4 protein was expressed in most (93.7%) ESCC samples but it was not observed in esophageal mucosa. Some ESCC cells had the capacity to form tumorospheres; those with an Oct4(+)-rich cell phenotype had increased proliferation and Oct4 mRNA levels compared to those of differentiated cells in culture or xenograft tumors. The over-expression of Oct4 in ESCCs suggests that it is a potential target for ESCC therapy. Oct4 could be a useful tumor marker in an immunohistochemical panel designed to differentiate between ESCC and esophageal mucosa. Expression of Oct4 in tumorospheres might indicate the presence of a population of ECSCs and its expression in xenograft tumors suggests that Oct4 is also associated with tumor metastasis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21547540      PMCID: PMC3887652          DOI: 10.1007/s10059-011-2315-5

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  35 in total

Review 1.  The cancer stem cell paradigm: a new understanding of tumor development and treatment.

Authors:  Johnathan D Ebben; Daniel M Treisman; Michael Zorniak; Raman G Kutty; Paul A Clark; John S Kuo
Journal:  Expert Opin Ther Targets       Date:  2010-06       Impact factor: 6.902

Review 2.  On the stem cell origin of cancer.

Authors:  Stewart Sell
Journal:  Am J Pathol       Date:  2010-04-29       Impact factor: 4.307

3.  Role of SOX2 in maintaining pluripotency of human embryonic stem cells.

Authors:  Keiko Adachi; Hirofumi Suemori; Shin-Ya Yasuda; Norio Nakatsuji; Eihachiro Kawase
Journal:  Genes Cells       Date:  2010-04-09       Impact factor: 1.891

4.  Cancer statistics, 2008.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Taylor Murray; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2008-02-20       Impact factor: 508.702

5.  SOX2 is highly expressed in squamous cell carcinomas of the gastrointestinal tract.

Authors:  Kevin B Long; Jason L Hornick
Journal:  Hum Pathol       Date:  2009-08-27       Impact factor: 3.466

6.  Octamer 4 small interfering RNA results in cancer stem cell-like cell apoptosis.

Authors:  Tingsong Hu; Shanrong Liu; Deborah R Breiter; Fang Wang; Ying Tang; Shuhan Sun
Journal:  Cancer Res       Date:  2008-08-15       Impact factor: 12.701

7.  Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma.

Authors:  Shih-Hwa Chiou; Cheng-Chia Yu; Chi-Yang Huang; Shu-Chun Lin; Chung-Ji Liu; Tung-Hu Tsai; Shiu-Huey Chou; Chian-Shiu Chien; Hung-Hai Ku; Jeng-Fan Lo
Journal:  Clin Cancer Res       Date:  2008-07-01       Impact factor: 12.531

8.  Oct4, a novel marker for human gastric cancer.

Authors:  Zhong Chen; Wen-Rong Xu; Hui Qian; Wei Zhu; Xue-Feng Bu; Sheng Wang; Yong-Min Yan; Fei Mao; Hong-Bing Gu; Hui-Ling Cao; Xue-Jing Xu
Journal:  J Surg Oncol       Date:  2009-06-01       Impact factor: 3.454

9.  SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity.

Authors:  Rosaria Maria Rita Gangemi; Fabrizio Griffero; Daniela Marubbi; Marzia Perera; Maria Cristina Capra; Paolo Malatesta; Gian Luigi Ravetti; Gian Luigi Zona; Antonio Daga; Giorgio Corte
Journal:  Stem Cells       Date:  2009-01       Impact factor: 6.277

Review 10.  Cancer stem cells: the lessons from pre-cancerous stem cells.

Authors:  Jian-Xin Gao
Journal:  J Cell Mol Med       Date:  2007-12-05       Impact factor: 5.310

View more
  12 in total

1.  Cancer stem-like cells contribute to paclitaxel resistance in esophageal squamous cell carcinoma.

Authors:  Yanru Shen; Lihui Yang; Lei Li
Journal:  Int J Clin Exp Pathol       Date:  2022-04-15

2.  Coexpression of HMGA2 and Oct4 predicts an unfavorable prognosis in human gastric cancer.

Authors:  Dequan Kong; Guoqiang Su; Lang Zha; Hongyu Zhang; Jifeng Xiang; Wei Xu; Yucheng Tang; Ziwei Wang
Journal:  Med Oncol       Date:  2014-07-19       Impact factor: 3.064

3.  Deoxycholic acid (DCA) confers an intestinal phenotype on esophageal squamous epithelium via induction of the stemness-associated reprogramming factors OCT4 and SOX2.

Authors:  Caifei Shen; Haoxiang Zhang; Pu Wang; Ji Feng; Jingwen Li; Yin Xu; Anran Zhang; Shunzi Shao; Xiaona Yu; Wu Yan; Yiju Xia; Jiali Hu; Dianchun Fang
Journal:  Cell Cycle       Date:  2016-04-20       Impact factor: 4.534

4.  Forthcoming prognostic markers for esophageal cancer: a systematic review and meta-analysis.

Authors:  Vinayak Nagaraja; Guy D Eslick
Journal:  J Gastrointest Oncol       Date:  2014-02

Review 5.  Dedifferentiation and reprogramming: origins of cancer stem cells.

Authors:  Dinorah Friedmann-Morvinski; Inder M Verma
Journal:  EMBO Rep       Date:  2014-02-14       Impact factor: 8.807

6.  OCT4 expression and vasculogenic mimicry formation positively correlate with poor prognosis in human breast cancer.

Authors:  Tieju Liu; Baocun Sun; Xiulan Zhao; Yanlei Li; Qiang Gu; Xueyi Dong; Fang Liu
Journal:  Int J Mol Sci       Date:  2014-10-28       Impact factor: 5.923

7.  Ectopic expression of TWIST1 upregulates the stemness marker OCT4 in the esophageal squamous cell carcinoma cell line KYSE30.

Authors:  Mohammad Hossein Izadpanah; Mohammad Reza Abbaszadegan; Yasaman Fahim; Mohammad Mahdi Forghanifard
Journal:  Cell Mol Biol Lett       Date:  2017-12-29       Impact factor: 5.787

8.  OCT4 positively regulates Survivin expression to promote cancer cell proliferation and leads to poor prognosis in esophageal squamous cell carcinoma.

Authors:  Chunguang Li; Yan Yan; Weidan Ji; Longlong Bao; Haihua Qian; Lei Chen; Mengchao Wu; Hezhong Chen; Zhigang Li; Changqing Su
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

9.  Expression of OCT4A: the first step to the next stage of urothelial bladder cancer progression.

Authors:  Wojciech Jóźwicki; Anna A Brożyna; Jerzy Siekiera
Journal:  Int J Mol Sci       Date:  2014-09-11       Impact factor: 5.923

10.  Correlation of Cancer Stem-Cell Markers OCT4, SOX2, and NANOG with Clinicopathological Features and Prognosis in Operative Patients with Rectal Cancer.

Authors:  Liuping You; Xin Guo; Yuenan Huang
Journal:  Yonsei Med J       Date:  2018-01       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.